Centene Corporation
Centene Reaffirms 2024 EPS Guidance and Shifts Q4 Performance
Summary
On September 10, 2024, Centene Corporation reaffirmed its 2024 full year adjusted diluted EPS guidance of greater than $6.80. The company also reiterated a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4, projecting Q3 adjusted diluted EPS between $1.31 to $1.41 and the remainder in Q4. The Company remains encouraged by its progress in improving its Medicare Advantage stars program performance.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement